REST | EAT | MOVE
REST | EAT | MOVE
Matt and Chris Johnson
248. What If They're All Wrong About GLP-1 Medications?
21 minutes Posted Feb 5, 2025 at 9:00 am.
0:00
21:30
Download MP3
Show notes
In this thought-provoking episode, Matt challenges the current narrative surrounding GLP-1 medications (like Ozempic and Wegovy) and obesity treatment. He poses a crucial question: Are we focusing too much on survival instead of helping people truly thrive?Key Points: • The difference between surviving and thriving in healthcare • Why treating obesity as purely a genetic disease might be misguided • Three major concerns about GLP-1 medications:* Downstream effects (vitamin absorption, gut health, muscle loss)* Loss of essential healthy habits* No clear exit strategy from the medication